The Wharton Health Care Management Alumni Association is pleased to share the following invitation from The HBS Healthcare Alumni Association
The Future of Immuno-Oncology: Combination Treatments
Tuesday, November 14, 2017
Immuno-oncology treatments have provided renewed hope to cancer patients. Combination treatments bring the promise of increased efficacy with manageable side effects. Come hear from experts about what the future may bring.
Norman Selby, Board of Trustees at Memorial Sloan Kettering, Executive Chairman of RealEndpoints and PAIGE.AI, former Senior Partner at McKinsey